SEEL logo

Seelos Therapeutics (SEEL) Total Liabilities

Annual Total Liabilities

$38.93 M
+$5.57 M+16.70%

December 31, 2023

Summary

Performance

1-Year Change

+16.7%

3-Year Change

+160.88%

5-Year Change

+3176.77%

15-Year Change

+1567.15%

SEEL Total Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$38.93 M
SEEL annual total liabilities is currently at an all-time high

3-Year Low

$26.18 M
SEEL annual total liabilities is currently +48.71% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
SEEL previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

N/A
SEEL next annual earnings announcement has not yet been scheduled

OtherSEELbalance sheetmetrics:

Quarterly Current Liabilities

$30.51 M
SEEL quarterly total current liabilities is $30.51 million

Quarterly Long Term Liabilities

$0.00
SEEL quarterly total long term liabilities is $0.00

Quarterly Total Assets

$2.38 M
SEEL quarterly total assets is $2.38 million

Quarterly Current Assets

$2.33 M
SEEL quarterly total current assets is $2.33 million

Quarterly Total Liabilities

$30.51 M
-$6.20 M-16.89%

June 30, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

0%

3-Year Change

0%

5-Year Change

+471.42%

SEEL Quarterly Total Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$59.07 M
SEEL quarterly total liabilities is currently -48.34% below its historical high of $59.07 million

3-Year Low

$25.06 M
SEEL quarterly total liabilities is currently +21.78% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2024
SEEL previous earnings announcement was published on Jun 30, 2024

Next Quarterly Earnings Report Date

N/A
SEEL next earnings announcement has not yet been scheduled

OtherSEELbalance sheetmetrics:

Quarterly Current Liabilities

$30.51 M
SEEL quarterly total current liabilities is $30.51 million

Quarterly Long Term Liabilities

$0.00
SEEL quarterly total long term liabilities is $0.00

Quarterly Total Assets

$2.38 M
SEEL quarterly total assets is $2.38 million

Quarterly Current Assets

$2.33 M
SEEL quarterly total current assets is $2.33 million

Total Liabilities Formula

Total Liabilities = Current Liabilities + Long-Term Liabilities

Annual Total Liabilities

$38.93 M
SEEL annual total liabilities is $38.93 million

Annual Current Liabilities

$38.93 M
SEEL annual total current liabilities is $38.93 million

Annual Total Long Term Liabilities

$0.00
SEEL annual total long term liabilities is $0.00

SEEL Total Liabilities Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+16.7%0.0%
3 y3 years+160.9%0.0%
5 y5 years+3176.8%+471.4%

SEEL Total Liabilities Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high-32.8%-48.3%-17.9%
5 y5-yearat high-71.5%-48.3%-89.6%
alltimeall timeat high-98.2%-48.3%-99.0%

Seelos Therapeutics Total Liabilities History

DateAnnualQuarterly
Jun 2024
-
$30.51 M(-16.9%)
Mar 2024
-
$36.72 M(-5.7%)
Dec 2023
$38.93 M(+16.7%)
$38.93 M(+6.3%)
Sep 2023
-
$36.63 M(-38.0%)
Jun 2023
-
$59.07 M(+33.3%)
Mar 2023
-
$44.30 M(+32.8%)
Dec 2022
$33.36 M(+27.4%)
$33.36 M(+2.2%)
Sep 2022
-
$32.63 M(+23.4%)
Jun 2022
-
$26.44 M(+5.5%)
Mar 2022
-
$25.06 M(-4.3%)
Dec 2021
$26.18 M(+75.4%)
$26.18 M(+225.8%)
Sep 2021
-
$8.03 M(+5.6%)
Jun 2021
-
$7.61 M(-54.2%)
Mar 2021
-
$16.61 M(+11.3%)
Dec 2020
$14.92 M(+34.4%)
$14.92 M(+368.4%)
Sep 2020
-
$3.19 M(-21.4%)
Jun 2020
-
$4.05 M(-45.3%)
Mar 2020
-
$7.41 M(-33.3%)
Dec 2019
$11.10 M(+834.6%)
$11.10 M(+89.4%)
Sep 2019
-
$5.86 M(+9.8%)
Jun 2019
-
$5.34 M(-42.6%)
Mar 2019
-
$9.31 M(+683.4%)
Dec 2018
$1.19 M(-49.1%)
$1.19 M(-18.1%)
Sep 2018
-
$1.45 M(-25.1%)
Jun 2018
-
$1.94 M(+11.9%)
Mar 2018
-
$1.73 M(-25.8%)
Dec 2017
$2.33 M(-80.9%)
$2.33 M(-6.7%)
Sep 2017
-
$2.50 M(+11.6%)
Jun 2017
-
$2.24 M(-50.3%)
Mar 2017
-
$4.51 M(-63.1%)
Dec 2016
$12.22 M(-31.1%)
$12.22 M(-23.4%)
Sep 2016
-
$15.95 M(+2.2%)
Jun 2016
-
$15.61 M(-9.7%)
Mar 2016
-
$17.27 M(-2.5%)
Dec 2015
$17.73 M(+37.5%)
$17.73 M(+1.2%)
Sep 2015
-
$17.51 M(+19.6%)
Jun 2015
-
$14.64 M(-18.5%)
Mar 2015
-
$17.97 M(+39.4%)
Dec 2014
$12.89 M(+4.5%)
$12.89 M(+65.3%)
Sep 2014
-
$7.80 M(-7.6%)
Jun 2014
-
$8.44 M(-47.6%)
Mar 2014
-
$16.10 M(+30.5%)
Dec 2013
$12.34 M(-28.5%)
$12.34 M(+19.2%)
Sep 2013
-
$10.35 M(-23.5%)
Jun 2013
-
$13.53 M(-21.5%)
Mar 2013
-
$17.24 M(-0.1%)
Dec 2012
$17.26 M(+46.3%)
$17.26 M(+0.3%)
Sep 2012
-
$17.21 M(+39.3%)
Jun 2012
-
$12.36 M(+5.6%)
Mar 2012
-
$11.70 M(-0.8%)
DateAnnualQuarterly
Dec 2011
$11.80 M(+61.7%)
$11.80 M(+53.2%)
Sep 2011
-
$7.70 M(-9.5%)
Jun 2011
-
$8.51 M(+13.6%)
Mar 2011
-
$7.49 M(+2.7%)
Dec 2010
$7.30 M(-60.0%)
$7.30 M(+6.3%)
Sep 2010
-
$6.87 M(-6.8%)
Jun 2010
-
$7.37 M(-56.8%)
Mar 2010
-
$17.05 M(-6.4%)
Dec 2009
$18.23 M(+159.5%)
$18.23 M(+263.5%)
Sep 2009
-
$5.01 M(-21.0%)
Jun 2009
-
$6.35 M(-4.7%)
Mar 2009
-
$6.66 M(-5.2%)
Dec 2008
$7.03 M(+19.7%)
$7.03 M(-14.4%)
Sep 2008
-
$8.21 M(+5.8%)
Jun 2008
-
$7.76 M(+31.1%)
Mar 2008
-
$5.92 M(+0.9%)
Dec 2007
$5.87 M(-30.4%)
$5.87 M(+26.2%)
Sep 2007
-
$4.65 M(-1.5%)
Jun 2007
-
$4.72 M(-42.5%)
Mar 2007
-
$8.21 M(-2.6%)
Dec 2006
$8.43 M(-33.6%)
$8.43 M(-14.8%)
Sep 2006
-
$9.90 M(-1.1%)
Jun 2006
-
$10.01 M(-9.0%)
Mar 2006
-
$11.00 M(-13.4%)
Dec 2005
$12.69 M(+43.1%)
$12.69 M(-10.3%)
Sep 2005
-
$14.15 M(+19.7%)
Jun 2005
-
$11.82 M(+38.3%)
Mar 2005
-
$8.55 M(-3.7%)
Dec 2004
$8.87 M(-14.8%)
$8.87 M(-4.1%)
Sep 2004
-
$9.25 M(-11.8%)
Jun 2004
-
$10.49 M(+2.0%)
Mar 2004
-
$10.28 M(-1.3%)
Dec 2003
$10.41 M(-4.6%)
$10.41 M(+147.8%)
Sep 2003
-
$4.20 M(-28.2%)
Jun 2003
-
$5.85 M(-38.4%)
Mar 2003
-
$9.49 M(-13.1%)
Dec 2002
$10.92 M(+240.4%)
$10.92 M(+53.8%)
Sep 2002
-
$7.10 M(-5.5%)
Jun 2002
-
$7.51 M(+181.0%)
Mar 2002
-
$2.67 M(-16.6%)
Dec 2001
$3.21 M(+157.5%)
$3.21 M(+63.3%)
Sep 2001
-
$1.96 M(+77.7%)
Jun 2001
-
$1.11 M(-14.1%)
Mar 2001
-
$1.29 M(+3.3%)
Dec 2000
$1.25 M(+77.9%)
$1.25 M(+159.7%)
Sep 2000
-
$479.60 K(+50.7%)
Jun 2000
-
$318.20 K(-24.7%)
Mar 2000
-
$422.80 K
Dec 1999
$700.00 K(-91.6%)
-
Dec 1998
$8.32 M(+155.1%)
-
Dec 1997
$3.26 M
-

FAQ

  • What is Seelos Therapeutics annual total liabilities?
  • What is the all time high annual total liabilities for Seelos Therapeutics?
  • What is Seelos Therapeutics annual total liabilities year-on-year change?
  • What is Seelos Therapeutics quarterly total liabilities?
  • What is the all time high quarterly total liabilities for Seelos Therapeutics?
  • What is Seelos Therapeutics quarterly total liabilities year-on-year change?

What is Seelos Therapeutics annual total liabilities?

The current annual total liabilities of SEEL is $38.93 M

What is the all time high annual total liabilities for Seelos Therapeutics?

Seelos Therapeutics all-time high annual total liabilities is $38.93 M

What is Seelos Therapeutics annual total liabilities year-on-year change?

Over the past year, SEEL annual total liabilities has changed by +$5.57 M (+16.70%)

What is Seelos Therapeutics quarterly total liabilities?

The current quarterly total liabilities of SEEL is $30.51 M

What is the all time high quarterly total liabilities for Seelos Therapeutics?

Seelos Therapeutics all-time high quarterly total liabilities is $59.07 M

What is Seelos Therapeutics quarterly total liabilities year-on-year change?

Over the past year, SEEL quarterly total liabilities has changed by $0.00 (0.00%)